# Vascular Inflammation in Psoriasis Trial (The VIP Trial)

> **NCT01553058** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 97 (actual)

## Conditions studied

- Psoriasis
- Cardiovascular Disease

## Interventions

- **DRUG:** Adalimumab (Humira)
- **DRUG:** Placebo Injection
- **OTHER:** NB-UVB phototherapy

## Key facts

- **NCT ID:** NCT01553058
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-08-08
- **Final completion:** 2016-10-27
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553058, "Vascular Inflammation in Psoriasis Trial (The VIP Trial)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01553058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*